Pope Francis is eating and intravenous feeding has never been mentioned, the Vatican said as he continues to battle pneumonia ...

After patients had undergone a 3-week run-in of subcutaneous darbepoetin alfa, they were randomized 1:1 to receive either subcutaneous or intravenous darbepoetin alfa once a week for 20 weeks ...

In this randomized trial, intraosseous-first vascular access did not result in higher 30-day survival than intravenous-first ...

The following is a summary of “Discarded intravenous medication in the ICU: the GAME-OVER multicenter prospective observational study,” published in the February 2025 issue of Critical Care by ...

Researchers from Revolo Biotherapeutics Ltd. recently presented preclinical data for IRL-201104, a clinical-stage ...

Switching from established intravenous (IV) therapy to subcutaneous infliximab was associated with high treatment persistence, stable clinical disease activity, and consistent faecal calprotectin ...

our study was limited by low power to detect an effect in a small but clinically important fraction of patients receiving the combination of high-dose intravenous calcium and concurrent ceftriaxone.

Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge ...

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...

People can take these orally or through an intravenous (IV) line. Medicare helps pay for chemotherapy deemed medically necessary. How a person receives the treatment and in what setting determines ...

The approval was supported by data from the registry-linked, parallel group, open-label, randomized AcT trial, which compared tenecteplase to alteplase.